This Month in Science

Research, ScienceJuly 4, 2015

TMIS | Evolocumab + Dr. Haussler

By Yael Kusne

This month in science…

We learned that evolocumab, a monoclonal antibody inhibiting proprotein convertase subtilisin-kexin type 9 (PCSK9), reduces low-density lipoprotein (LDL) cholesterol levels.